181 related articles for article (PubMed ID: 29299304)
1. Antimicrobial susceptibility of
Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
Deshmukh A; Hagen F; Sharabasi OA; Abraham M; Wilson G; Doiphode S; Maslamani MA; Meis JF
BMC Microbiol; 2015 Jun; 15():121. PubMed ID: 26073177
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
[TBL] [Abstract][Full Text] [Related]
5. The canonical Brucella species-host dependency is changing, however, the antibiotic susceptibility profiles remain unchanged.
Celik E; Kayman T; Buyuk F; Gulmez Saglam A; Abay S; Akar M; Karakaya E; Balkan Bozlak CE; Coskun MR; Buyuk E; Celebi O; Sahin M; Saticioglu IB; Durhan S; Baykal A; Ersoy Y; Otlu S; Aydin F
Microb Pathog; 2023 Sep; 182():106261. PubMed ID: 37488036
[TBL] [Abstract][Full Text] [Related]
6. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.
Ariza J; Bosch J; Gudiol F; Liñares J; Viladrich PF; Martín R
Antimicrob Agents Chemother; 1986 Dec; 30(6):958-60. PubMed ID: 3813520
[TBL] [Abstract][Full Text] [Related]
7. In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
Ilhan Z; Solmaz H; Ekin IH
J Vet Med Sci; 2013; 75(8):1035-40. PubMed ID: 23545462
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Brucella melitensis isolates in Peru.
Maves RC; Castillo R; Guillen A; Espinosa B; Meza R; Espinoza N; Núñez G; Sánchez L; Chacaltana J; Cepeda D; González S; Hall ER
Antimicrob Agents Chemother; 2011 Mar; 55(3):1279-81. PubMed ID: 21199926
[TBL] [Abstract][Full Text] [Related]
9. Biotypes and antimicrobial susceptibilities of Brucella isolates.
Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey.
Sayan M; Kılıc S; Uyanık MH
J Infect Chemother; 2012 Feb; 18(1):41-6. PubMed ID: 21826587
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran.
Razzaghi R; Rastegar R; Momen-Heravi M; Erami M; Nazeri M
Indian J Med Microbiol; 2016; 34(3):342-5. PubMed ID: 27514957
[TBL] [Abstract][Full Text] [Related]
12. Reduced Susceptibility to Rifampicin and Resistance to Multiple Antimicrobial Agents among Brucella abortus Isolates from Cattle in Brazil.
Barbosa Pauletti R; Reinato Stynen AP; Pinto da Silva Mol J; Seles Dorneles EM; Alves TM; de Sousa Moura Souto M; Minharro S; Heinemann MB; Lage AP
PLoS One; 2015; 10(7):e0132532. PubMed ID: 26181775
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Diagnostic Aspects of Brucellosis and Antimicrobial Susceptibility of Brucella Isolates in Hamedan, Iran.
Torkaman Asadi F; Hashemi SH; Alikhani MY; Moghimbeigi A; Naseri Z
Jpn J Infect Dis; 2017 May; 70(3):235-238. PubMed ID: 27580575
[TBL] [Abstract][Full Text] [Related]
14. Tigecycline: its potential for treatment of brucellosis.
Dizbay M; Kilic S; Hizel K; Arman D
Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.
Turkmani A; Ioannidis A; Christidou A; Psaroulaki A; Loukaides F; Tselentis Y
Ann Clin Microbiol Antimicrob; 2006 Oct; 5():24. PubMed ID: 17014707
[TBL] [Abstract][Full Text] [Related]
16. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
18. [E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].
Sengöz G; Yaşar KK; Kutlu SB; Durdu YB; Ozdemir R; Nazlican O
Mikrobiyol Bul; 2006 Jul; 40(3):265-8. PubMed ID: 17001857
[TBL] [Abstract][Full Text] [Related]
19. Mutant prevention concentrations of tetracycline, rifampicin and ciprofloxacin for Brucellae melitensis.
Coban AY; Tanyel E; Tasdelen Fisgin N; Darka O; Tulek N; Durupinar B
J Chemother; 2007 Oct; 19(5):596-8. PubMed ID: 18073161
[No Abstract] [Full Text] [Related]
20. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.
Marianelli C; Graziani C; Santangelo C; Xibilia MT; Imbriani A; Amato R; Neri D; Cuccia M; Rinnone S; Di Marco V; Ciuchini F
J Clin Microbiol; 2007 Sep; 45(9):2923-8. PubMed ID: 17634297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]